Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy
Public ClinicalTrials.gov record NCT01468350. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled, Crossover Study in Subjects With Cerebral Palsy to Evaluate the Safety and Tolerability and the Effect on Sensorimotor Function of Dalfampridine-ER
Study identification
- NCT ID
- NCT01468350
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Acorda Therapeutics
- Industry
- Enrollment
- 35 participants
Conditions and interventions
Conditions
Interventions
- dalfampridine-ER 10mg Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2011
- Primary completion
- Dec 31, 2012
- Completion
- Feb 28, 2013
- Last update posted
- Jun 23, 2014
2011 – 2013
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Rancho Los Amigos National Rehabilitation Center | Downey | California | 90242 | — |
| UCLA/Orthopaedic Hospital Center for Cerebral Palsy | Los Angeles | California | 90095 | — |
| Rady Children's Hospital San Diego | San Diego | California | 92123 | — |
| Rehabilitation Institute of Chicago | Chicago | Illinois | 60611 | — |
| Kennedy Krieger Institute at Johns Hopkins University | Baltimore | Maryland | 21205 | — |
| Detroit Clinical Research Center | Farmington Hills | Michigan | 48334 | — |
| Gillette Children's Specialty Healthcare | Saint Paul | Minnesota | 55101 | — |
| University of Missouri at Columbia | Columbia | Missouri | 65212 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Swedish Medical Center | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01468350, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2014 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01468350 live on ClinicalTrials.gov.